Cited by

• Glycosylated hemoglobin as a long-term parameter in appraising the severity of hemolytic disease.

  Panzer S, Graninger W, Kronik G, Bettelheim P, Lechner K. Panzer S, et al. Klin Wochenschr. 1983 Sep 1;61(17):839-43. doi: 10.1007/BF01537458. Klin Wochenschr. 1983. PMID: 6632725
• Detection of seven point mutations in the porphobilinogen deaminase gene in patients with acute intermittent porphyria, by direct sequencing of in vitro amplified cDNA.

  Mgone CS, Lanyon WG, Moore MR, Connor JM. Mgone CS, et al. Hum Genet. 1992 Sep-Oct;90(1-2):12-6. doi: 10.1007/BF00210738. Hum Genet. 1992. PMID: 1427766
• Tissue-specific splicing mutation in acute intermittent porphyria.

  Grandchamp B, Picat C, Mignotte V, Wilson JH, Te Velde K, Sandkuyl L, Roméo PH, Goossens M, Nordmann Y. Grandchamp B, et al. Proc Natl Acad Sci U S A. 1989 Jan;86(2):661-4. doi: 10.1073/pnas.86.2.661. Proc Natl Acad Sci U S A. 1989. PMID: 2563167 Free PMC article.
• Protoporphyrin IX: the Good, the Bad, and the Ugly.

  Sachar M, Anderson KE, Ma X. Sachar M, et al. J Pharmacol Exp Ther. 2016 Feb;356(2):267-75. doi: 10.1124/jpet.115.228130. Epub 2015 Nov 20. J Pharmacol Exp Ther. 2016. PMID: 26588930 Free PMC article. Review.
• A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress.

  Chen Q, Fabry ME, Rybicki AC, Suzuka SM, Balazs TC, Etzion Z, de Jong K, Akoto EK, Canterino JE, Kaul DK, Kuypers FA, Lefer D, Bouhassira EE, Hirsch RE. Chen Q, et al. Blood Cells Mol Dis. 2012 Feb 15;48(2):91-101. doi: 10.1016/j.bcmd.2011.12.002. Epub 2012 Jan 18. Blood Cells Mol Dis. 2012. PMID: 22260787 Free PMC article.